Nestle India and Dr Reddy to form a JV

The JV will focus on both Companies’ complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness, women’s health and child nutrition for consumers across India.

  • The JV will aim to extend the reach of Nestle‘s science-backed nutritional solutions to a broader customer base across the country by leveraging Dr. Reddy’s extensive retail and distribution network.
  • Select brands will be licensed by both the JV partners to the JV company.
  • JV is expected to be operational by Q2 of FY 2025.

Dr Reddy’s will hold a 51% stake in the JV, with Nestlé India holding the rest. Nestlé will have the option to increase its shareholding to up to 60% after six years, while Dr Reddy’s will retain a minimum of 40% shareholding even after Nestlé India exercises its call option.

Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x